Krilogy Financial’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-14,550
| Closed | -$1.19M | – | 286 |
|
|
2021
Q3 | $1.19M | Buy |
14,550
+148
| +1% | +$12.1K | 0.12% | 118 |
|
|
2021
Q2 | $1.31M | Buy |
14,402
+597
| +4% | +$54.5K | 0.13% | 109 |
|
|
2021
Q1 | $1.18M | Buy |
13,805
+5,778
| +72% | +$494K | 0.12% | 109 |
|
|
2020
Q4 | $758K | Buy |
8,027
+473
| +6% | +$44.7K | 0.09% | 144 |
|
|
2020
Q3 | $657K | Sell |
7,554
-1,461
| -16% | -$127K | 0.09% | 139 |
|
|
2020
Q2 | $787K | Buy |
+9,015
| New | +$787K | 0.12% | 114 |
|
|
2018
Q4 | – | Sell |
-1,285
| Closed | -$99K | – | 503 |
|
|
2018
Q3 | $99K | Buy |
+1,285
| New | +$99K | 0.02% | 220 |
|
|
2018
Q2 | – | Sell |
-728
| Closed | -$53K | – | 495 |
|
|
2018
Q1 | $53K | Buy |
728
+148
| +26% | +$10.8K | 0.01% | 316 |
|
|
2017
Q4 | $44K | Hold |
580
| – | – | 0.01% | 344 |
|
|
2017
Q3 | $45K | Buy |
580
+31
| +6% | +$2.41K | 0.01% | 355 |
|
|
2017
Q2 | $41K | Buy |
549
+28
| +5% | +$2.09K | 0.01% | 333 |
|
|
2017
Q1 | $34K | Hold |
521
| – | – | 0.01% | 344 |
|
|
2016
Q4 | $34K | Sell |
521
-34
| -6% | -$2.22K | 0.01% | 344 |
|
|
2016
Q3 | $39K | Hold |
555
| – | – | 0.01% | 336 |
|
|
2016
Q2 | $41K | Sell |
555
-78
| -12% | -$5.76K | 0.01% | 332 |
|
|
2016
Q1 | $41K | Buy |
633
+212
| +50% | +$13.7K | 0.02% | 292 |
|
|
2015
Q4 | $32K | Sell |
421
-111
| -21% | -$8.44K | 0.03% | 171 |
|
|
2015
Q3 | $44K | Buy |
+532
| New | +$44K | 0.02% | 220 |
|